Roberta Pannell
Oct 31, 2023 - 01:35

Eye Drop Recall Expanded Due to Bacteria, Fungus Contamination

Dr. Berne's Whole Health is recalling additional eye drops after the FDA found contamination in that brand as well as LightEyez, which has not issued a recall.

Dr. Berne's Whole Health is recalling additional eye drops after the Food and Drug Administration (FDA) discovered contamination in two brands of eye drops. The FDA issued a warning on August 22 against using Dr. Berne's MSM Drops 5% Solution and LightEyez MSM Eye Drops due to contamination. However, only Dr. Berne's Whole Health Products voluntarily recalled the mentioned products. On Tuesday, they announced a recall of all eye drop products, despite testing showing no contamination. Meanwhile, LightEyez continues to offer the eye drops on its website without responding to the FDA's communication or taking action to protect consumers.

The contamination issue is not the only concern with these eye drops. The FDA states that the inclusion of methylsulfonylmethane (MSM) as an active ingredient in these products is illegal. While MSM is a naturally occurring organosulfur compound that can aid in inflammation in the body, the FDA emphasizes that there are no legally marketed ophthalmic drugs that contain MSM as an active ingredient. The use of contaminated eye drops could lead to minor to serious vision-threatening infections, and potentially progress to life-threatening infections.

The FDA found that Dr. Berne's drops contained bacillus, which the CDC defines as a major pathogen, and exophiala, which the National Institute of Health classifies as an opportunistic fungus. Two reports of adverse events related to this recall have been received by the company. LightEyez, on the other hand, contained pseudomonas bacteria, which the CDC states is developing antibiotic resistance, along with three other types of bacteria.

It is crucial for consumers to be aware of this recall and discontinue the use of any unexpired eye drop products from these brands. The FDA's findings highlight the potential risks associated with using contaminated eye drops and the importance of ensuring that ophthalmic drugs on the market are legally approved and safe for use.